Clinical Trials Logo

Sclerosis clinical trials

View clinical trials related to Sclerosis.

Filter by:

NCT ID: NCT03806647 Recruiting - Clinical trials for Amyotrophic Lateral Sclerosis

Development and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS (Part 1)

Start date: September 1, 2018
Phase:
Study type: Observational

The research is aimed to explore the needs of clinical patients and their caregiver,so as to provide suggestions to the designer of the communication system.

NCT ID: NCT03804047 Recruiting - Multiple Sclerosis Clinical Trials

KITAMS: Kinesio Tape and Physical Function in Persons With Multiples Sclerosis

KITAMS
Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Multiple sclerosis (MS) is a disease that causes damage within the central nervous system and results in deficits of body functions. The investigators propose a pilot randomized controlled trial examining the acute effect of kinesio tape application in various body segments on balance, mobility, physical functioning, and pain in persons with MS (pwMS) aged 18 to 55 years old. The investigators will objectively assess balance using a force platform and mobility and physical functioning will be assessed using standardized tests (i.e., Timed Up and Go, Timed 25-foot Walk, 6-minute Step Test, Six Spot Step Test). The trial will recruit 24 pwMS aged 18 to 55 years with mild-to-moderate MS-related disability who will be randomized into intervention (Kinesio Tape) or control conditions (Sham/Inflexible Tape). Participants will complete assessments before and after tape application. This pilot trial will inform future research interventions aiming to use the approach in different situations with pwMS (e.g., exercise).

NCT ID: NCT03787446 Recruiting - Multiple Sclerosis Clinical Trials

PET Study in Multiple Sclerosis

Start date: March 26, 2019
Phase:
Study type: Observational

While both conventional and advanced MRI techniques offer important insights into MS pathophysiology, important aspects of this inflammatory disorder are undetectable with existing MRI technology. In Multiple Sclerosis (MS), there is growing interest in PET as an imaging modality that can increase the investigator's understanding of the disease processes and may add to an understanding of MS phenotype, particularly when combined with advanced MRI techniques such as myelin water imaging.

NCT ID: NCT03785483 Recruiting - Mindfulness Clinical Trials

Implementation Intention for Physical Activity in Multiple Sclerosis

apsep
Start date: December 30, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of an 8-week intervention based on implementation intention (motivation) in patients with multiple sclerosis on objectively measured physical activity.

NCT ID: NCT03784547 Recruiting - Multiple Sclerosis Clinical Trials

Real-world Data of Ocrelizumab in Multiple Sclerosis in LATAM

RWD_ocre
Start date: February 1, 2019
Phase:
Study type: Observational

It has been almost 25 years since the publication of the pivotal trial results for the first disease-modifying therapy (DMT) for RRMS. Currently disease modifying therapies (DMTs) for MS approved by the European Medicine Agency (EMA) and Food and Drug Administration (FDA) include interferon beta (IFNβ) 1-a and 1-b, glatiramer acetate (GA), mitoxantrone, natalizumab, fingolimod, teriflunomide, dimethyl fumarate, alemtuzumab, daclizumab and ocrelizumab. Despite evidence about ocrelizumab exist in many patients from eurpe and North America, scarce real world evidence exists about epidemiolofcal aspects of patients that used ocrelizumab in Latin America. The aim of this study is therefore to evaluate patient profiles and persistence to treatment during follow up in a retrospective study of patients who had been prescribed ocrelizumab for the treatment of MS in Latin America (LATAM). The investigators will include MS patients that received ocrelizumab in Latin America and describe epidemiological aspects and persistence to treatment during the last 12 months.

NCT ID: NCT03783416 Recruiting - Clinical trials for Relapsing Remitting Multiple Sclerosis

SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis

SIZOMUS
Start date: August 20, 2020
Phase: Phase 1
Study type: Interventional

The study seeks to investigate safety and efficacy of ixazomib (NINLARO), a proteasome inhibitor, in multiple sclerosis (MS). Participants will receive either ixazomib capsules or placebo capsules for up to 24 months.

NCT ID: NCT03737097 Recruiting - Clinical trials for Education of Patients

Online Spaced Education to Improve Fall Prevention by Patients With Multiple Sclerosis

Start date: February 21, 2019
Phase: N/A
Study type: Interventional

Multiple sclerosis (MS) is a chronic, progressive and neurodegenerative inflammatory disease that affects young adults. In many countries it has been described as the main cause of neurological incapacity in this age group. Due to the neurological impairment, patients with multiple sclerosis have a high incidence of fall. According to studies, MS patients fall three times more than general population. In the present study, the question to be answered is: education of individuals with MS on fall prevention using the method of online spaced education provides better retention of knowledge than the traditional method? This is a clinical trial to compare two methods of education of MS patients for prevention of fall. First stage: Development and validation of materials. Step two: Pilot questions with MS patients. Step three: Intervention and evaluation of outcome.

NCT ID: NCT03735823 Recruiting - Multiple Sclerosis Clinical Trials

IL-11 in the Development of Multiple Sclerosis

Start date: June 1, 2018
Phase:
Study type: Observational [Patient Registry]

Since the last submission, the investigator have further characterized the potential of IL--11 to induce encephalitogenic CD4+IL--17A+, IL--21+ and GM--CSF+ cells, which upon passive transfer induced severe RREAE with IL--17A+CCR6+ CD4+ cell, neutrophil, CD8+ and B--cell accumulation within the CNS (manuscript submitted for publication). These findings confirmed our hypothesis and further characterization of the IL--11--induced encephalitogenic CD4+ cells will be performed as planned in the grant proposal

NCT ID: NCT03723434 Recruiting - Healthy Clinical Trials

Physiology of Interregional Connectivity in the Human Brain

Start date: May 31, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to understand the physiology of connectivity between cortical regions in the human brain in healthy participants and in patients with white matter lesions. Specifically, the investigators will examine the effects of paired associative stimulation (PAS) which consists in delivering brief (< 1 ms) current pulses separated by a short millisecond-level time interval ("asynchrony") to two cortical areas. The used techniques are all non-invasive and considered safe in humans: transcranial magnetic stimulation (TMS), electroencephalography (EEG), magnetic resonance imaging (MRI), and functional MRI (fMRI). Based on prior literature in animals and human studies, it is hypothesized that PAS may increase or decrease effective connectivity between the stimulated areas depending on the asynchrony value. The main outcome measure is source-resolved EEG responses evoked by single-pulse TMS; this is a more direct measure of neuronal changes occurring at the targeted cortical area than motor evoked potentials (MEPs) or sensor-level EEG responses used in previous studies.

NCT ID: NCT03718819 Recruiting - Multiple Sclerosis Clinical Trials

Effects of Exercises in MS on Postural Control With Dual Task

MScombined
Start date: March 1, 2018
Phase: N/A
Study type: Interventional

Multiple sclerosis is a progressive neurological disease that associated with demyelinization and axonal damage. Decreased postural control is one of the initial symptom of disease. Improving postural control in people with neurological impairment is a common goal of physiotherapy. Doing exercises in water or land are examples for effective solutions. Pilates and aquaplyometric exercises are some of these approaches. Performing daily activities at the same time requires dual tasking or multi tasking. Dual tasking is frequently impaired in MS. The aim of the study was to determine effect of combined Pilates and Aquaplyometric exercises on postural control with or without dual task in patients with multiple sclerosis.